Literature DB >> 33127759

Dissecting heterogeneous cell populations across drug and disease conditions with PopAlign.

Sisi Chen1,2, Paul Rivaud3,2, Jong H Park3,2, Tiffany Tsou3,2, Emeric Charles4, John R Haliburton5, Flavia Pichiorri6, Matt Thomson1,2.   

Abstract

Single-cell measurement techniques can now probe gene expression in heterogeneous cell populations from the human body across a range of environmental and physiological conditions. However, new mathematical and computational methods are required to represent and analyze gene-expression changes that occur in complex mixtures of single cells as they respond to signals, drugs, or disease states. Here, we introduce a mathematical modeling platform, PopAlign, that automatically identifies subpopulations of cells within a heterogeneous mixture and tracks gene-expression and cell-abundance changes across subpopulations by constructing and comparing probabilistic models. Probabilistic models provide a low-error, compressed representation of single-cell data that enables efficient large-scale computations. We apply PopAlign to analyze the impact of 40 different immunomodulatory compounds on a heterogeneous population of donor-derived human immune cells as well as patient-specific disease signatures in multiple myeloma. PopAlign scales to comparisons involving tens to hundreds of samples, enabling large-scale studies of natural and engineered cell populations as they respond to drugs, signals, or physiological change.

Entities:  

Keywords:  probabilistic models; single cell mRNA-seq; single-cell genomics

Mesh:

Year:  2020        PMID: 33127759      PMCID: PMC7682438          DOI: 10.1073/pnas.2005990117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain.

Authors:  Gabrielle Faure-André; Pablo Vargas; Maria-Isabel Yuseff; Mélina Heuzé; Jheimmy Diaz; Danielle Lankar; Veronica Steri; Jeremy Manry; Stéphanie Hugues; Fulvia Vascotto; Jérôme Boulanger; Graça Raposo; Maria-Rosa Bono; Mario Rosemblatt; Matthieu Piel; Ana-Maria Lennon-Duménil
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

2.  Glucocorticoids induce effector T cell depolarization via ERM proteins, thereby impeding migration and APC conjugation.

Authors:  Nora Müller; Henrike J Fischer; Denise Tischner; Jens van den Brandt; Holger M Reichardt
Journal:  J Immunol       Date:  2013-03-08       Impact factor: 5.422

Review 3.  Signaling in innate immunity and inflammation.

Authors:  Kim Newton; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

4.  Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.

Authors:  Peter van Galen; Volker Hovestadt; Marc H Wadsworth Ii; Travis K Hughes; Gabriel K Griffin; Sofia Battaglia; Julia A Verga; Jason Stephansky; Timothy J Pastika; Jennifer Lombardi Story; Geraldine S Pinkus; Olga Pozdnyakova; Ilene Galinsky; Richard M Stone; Timothy A Graubert; Alex K Shalek; Jon C Aster; Andrew A Lane; Bradley E Bernstein
Journal:  Cell       Date:  2019-02-28       Impact factor: 41.582

5.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.

Authors:  Kenneth J Pienta; Natalie McGregor; Robert Axelrod; David E Axelrod
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

Review 6.  Myeloid-derived suppressor cells: The green light for myeloma immune escape.

Authors:  Ehsan Malek; Marcos de Lima; John J Letterio; Byung-Gyu Kim; James H Finke; James J Driscoll; Sergio A Giralt
Journal:  Blood Rev       Date:  2016-04-12       Impact factor: 8.250

7.  Integrating single-cell transcriptomic data across different conditions, technologies, and species.

Authors:  Andrew Butler; Paul Hoffman; Peter Smibert; Efthymia Papalexi; Rahul Satija
Journal:  Nat Biotechnol       Date:  2018-04-02       Impact factor: 54.908

Review 8.  The Principles of Engineering Immune Cells to Treat Cancer.

Authors:  Wendell A Lim; Carl H June
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

9.  Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma.

Authors:  T Dosani; F Covut; R Beck; J J Driscoll; M de Lima; E Malek
Journal:  Blood Cancer J       Date:  2017-06-30       Impact factor: 11.037

10.  IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts.

Authors:  Marina Bolzoni; Domenica Ronchetti; Paola Storti; Gaetano Donofrio; Valentina Marchica; Federica Costa; Luca Agnelli; Denise Toscani; Rosanna Vescovini; Katia Todoerti; Sabrina Bonomini; Gabriella Sammarelli; Andrea Vecchi; Daniela Guasco; Fabrizio Accardi; Benedetta Dalla Palma; Barbara Gamberi; Carlo Ferrari; Antonino Neri; Franco Aversa; Nicola Giuliani
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

View more
  2 in total

1.  Whole-animal multiplexed single-cell RNA-seq reveals transcriptional shifts across Clytia medusa cell types.

Authors:  Tara Chari; Brandon Weissbourd; Jase Gehring; Anna Ferraioli; Lucas Leclère; Makenna Herl; Fan Gao; Sandra Chevalier; Richard R Copley; Evelyn Houliston; David J Anderson; Lior Pachter
Journal:  Sci Adv       Date:  2021-11-26       Impact factor: 14.957

2.  Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction.

Authors:  Manav Gandhi; Viral Bakhai; Jash Trivedi; Adarsh Mishra; Fernando De Andrés; Adrián LLerena; Rohit Sharma; Sujit Nair
Journal:  Transl Oncol       Date:  2022-09-11       Impact factor: 4.803

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.